Skip to main content
OpenTrials

Clinical trial condition

Bile Duct Neoplasms

Explore clinical trials studying Bile Duct Neoplasms. Study availability and eligibility vary by location and protocol.

169 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Bile Duct Neoplasms trial results

Recruiting

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

NCT07186842

Conditions
Adnexal Diseases, Advanced Solid Cancers, Bile Duct Diseases, +29 more
Locations
  • SCRI at HCA Health One Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Monash Health Clayton, Australia
View all 17 locations
View Trial Details
Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma

NCT05874414

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +10 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • LACN Aneheim Flagship Office Los Angeles, California, United States
  • Orlando Health Orlando, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details

Related conditions